Management addresses Q3 earnings and more
Results largely exceed analyst expectations, though
Battle against endometriosis continues
Share purchase programme is far from over, though
Particularly in relation to Vraylar
10% growth forecast raised
Q2 report due on Friday
Plans to become a leader in WH by end of the decade
In Brazil
Transaction closed
Exchange rates to have adverse affect this year
Pharma firm publishes first quarter results
Here's the fresh consensus
Annual General Meeting takes decision
This sum has certainly lost its public money character
With high target price
BoD decides
However, turnover fell sharply in February on the Budapest Stock Exchange
New rules in effect as of today
Several records were achieved last year, though